Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Effect of metformin (MT), vitamin D3 (D3), and their combination (MT + D3) on oral glucose tolerance in Swiss albino mice.
Source: Oral Glucose Tolerance Test. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Animal research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Swiss albino mice were made diabetic using STZ (45 mg/kg) injected intraperitoneally for 3 days.
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Exploring the Therapeutic Potential of Metformin and Vitamin D3 Combination in the Management of Diabetes Mellitus
Study design awaiting verification · Endocrinology, Diabetes & Metabolism · 2026
Original publication title
Exploring the Therapeutic Potential of Metformin and Vitamin D3 Combination in the Management of Diabetes Mellitus
© 2026 The Author(s). Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Diabetes mellitus is a chronic metabolic disorder characterised by hyperglycaemia, dyslipidaemia, hepatic dysfunction, and loss of pancreatic β‐cells. Vitamin D3 (D3) may influence glucose and lipid metabolism and has been investigated for its potential complementary effects when administered with metformin (MT). In the present study, the anti‐diabetic activity of D3 alone and when combined with MT was evaluated in Streptozotocin (STZ) induced diabetic mice.
Source: BackgroundAbstract: What methods does the paper describe?
Swiss albino mice were made diabetic using STZ (45 mg/kg) injected intraperitoneally for 3 days. Diabetic mice were treated with MT (250 mg/kg), D3 (100 μg/kg), or MT + D3 for 21 days. The fasting blood glucose, serum lipid profile, body weight, alanine aminotransferase (ALT), and pancreatic histopathology were assessed. The data were analysed by ANOVA and Tukey's post hoc test, and a p‐value < 0.05 was considered statistically significant.
Source: MethodsAbstract: Results
The diabetic STZ mice showed sustained hyperglycaemia, weight loss, dyslipidaemia, increased ALT activity and degeneration of the islets of Langerhans. MT and D3 treatments were associated with improvements in glycaemic control, and the combination treatment showed the greatest effect. Combined treatment was found to lower the level of total cholesterol (93.06 ± 2.89 mg/dL), LDL (28.66 mg/dL), triglycerides (120.33 ± 2.10 mg/dL) and ALT activity (52.60 ± 3.05 IU/L) and increase HDL (40.33 ± 2.10 mg/dL) when compared with diabetic controls.
Moreover, the MT + D3 group exhibited significant changes in the total cholesterol/HDL and LDL/HDL ratio and preserved the histoarchitecture of the pancreas.
Source: ResultsAbstract: Conclusion
Metformin and vitamin D3, administered individually or in combination, were associated with improvements in several diabetes‐related metabolic parameters. The combination group showed greater observed metabolic outcomes than either treatment alone in STZ‐induced diabetic mice. Further adequately powered preclinical and clinical studies are required to determine the therapeutic relevance of this combination.
Source: ConclusionAuthors’ abstract
ABSTRACT
Background
Diabetes mellitus is a chronic metabolic disorder characterised by hyperglycaemia, dyslipidaemia, hepatic dysfunction, and loss of pancreatic β‐cells. Vitamin D3 (D3) may influence glucose and lipid metabolism and has been investigated for its potential complementary effects when administered with metformin (MT). In the present study, the anti‐diabetic activity of D3 alone and when combined with MT was evaluated in Streptozotocin (STZ) induced diabetic mice.
Methods
Swiss albino mice were made diabetic using STZ (45 mg/kg) injected intraperitoneally for 3 days. Diabetic mice were treated with MT (250 mg/kg), D3 (100 μg/kg), or MT + D3 for 21 days. The fasting blood glucose, serum lipid profile, body weight, alanine aminotransferase (ALT), and pancreatic histopathology were assessed. The data were analysed by ANOVA and Tukey's post hoc test, and a p‐value < 0.05 was considered statistically significant.
Results
The diabetic STZ mice showed sustained hyperglycaemia, weight loss, dyslipidaemia, increased ALT activity and degeneration of the islets of Langerhans. MT and D3 treatments were associated with improvements in glycaemic control, and the combination treatment showed the greatest effect. Combined treatment was found to lower the level of total cholesterol (93.06 ± 2.89 mg/dL), LDL (28.66 mg/dL), triglycerides (120.33 ± 2.10 mg/dL) and ALT activity (52.60 ± 3.05 IU/L) and increase HDL (40.33 ± 2.10 mg/dL) when compared with diabetic controls.
Moreover, the MT + D3 group exhibited significant changes in the total cholesterol/HDL and LDL/HDL ratio and preserved the histoarchitecture of the pancreas.
Conclusion
Metformin and vitamin D3, administered individually or in combination, were associated with improvements in several diabetes‐related metabolic parameters. The combination group showed greater observed metabolic outcomes than either treatment alone in STZ‐induced diabetic mice. Further adequately powered preclinical and clinical studies are required to determine the therapeutic relevance of this combination.
Publication and source details
Original title: Exploring the Therapeutic Potential of Metformin and Vitamin D3 Combination in the Management of Diabetes Mellitus
Md. Ferdaus Azam; Md. Abu Bakar Siddique Jami; Nafis Yamin Suprio; Md. Ismail Kabir; Sabrina Tasnim Oishi; Jannatul Ferdous Ekra; Nusrat Islam; Samia Zaman; Md. Mofazzal Hossain; Md. Al Amin
Endocrinology, Diabetes & Metabolism · 2026
* Correspondence:Md. Mofazzal Hossain (mofazzal.hossain@uits.ac.bd)
Md. Al Amin (md.alamin869@uits.edu.bd)
© 2026 The Author(s). Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-06T22:32:11+00:00
DOI: 10.1002/edm2.70384 · PMC13724220